Navigation Links
Research links 29 genome regions with common form of inflammatory bowel disease
Date:2/6/2011

An international team of researchers has made new links between 29 regions of the genome and ulcerative colitis a common form of inflammatory bowel disease (IBD). The new findings increase the total number of genome regions known to be associated with inflammatory bowel disease to 99.

The results point to several biological processes, including the way that our bodies maintain the lining of the intestinal wall, which are likely to play an important role in the development of ulcerative colitis.

The causes of inflammatory bowel disease are not fully understood, although it is thought that patients with inflammatory bowel disease have an overactive immune response against typical gut contents. Together, ulcerative colitis and Crohn's disease the two primary causes of inflammatory bowel disease affect one in 250 people in Europe, North America and Australasia.

Unlike Crohn's disease, which can impair any part of the human digestive tract, ulcerative colitis is restricted to the large bowel. Up to 20 per cent of ulcerative colitis patients will require surgery to remove the entire large bowel.

"The outcomes and quality of life for patients with ulcerative colitis can be bleak", says Dr. John Rioux, from the Montreal Heart Institute and the Universit de Montral, senior author on the paper, and co-chair of the International IBD Genetics Consortium. "To understand the genetic causes of the disease, we carried out the largest study of the disease to date taking a magnifying glass to over one million sites in the genomes of more than 26,000 people."

"Ultimately, we hope that unmasking the genetic processes that give rise to the disease will minimise the need for surgical outcomes, by opening the door for new therapies that can stop the disease in its tracks."

"With one in 160 Canadians living with either Crohn's disease or ulcerative colitis, we have among the highest rates of IBD in the world," says Dr. Kevin G
'/>"/>

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Just in time for Valentines Day: UNC researchers identify a gene critical for heart function
2. Johns Hopkins researchers capture jumping genes
3. The brain knows what the nose smells, but how? Stanford researchers trace the answer
4. Scientific research reveals brain alterations linking omega 3 deficit with depression
5. Arctic fisheries catches 75 times higher than previous reports: UBC research
6. Cornell researchers find a strong community protects adolescents from risky health behavior
7. Scientists urge new research policies in wake of Gulf disaster
8. First new C. difficile drug in a generation superior to existing treatments: Researchers
9. State of the Union focuses on research, education and innovation
10. Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
11. Researchers test inhalable measles vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2014)... Calif. , Dec. 4, 2014 ... has boosted investments in new testing and inspection ... also given rise to a range of innovative ... the requirements of Generation Y, which is generally ... As a result, product development strategies of test ...
(Date:12/4/2014)... GARDENS, Fla. , Dec. 3, 2014 /PRNewswire/ ... solutions, today announced that its DigitalPersona ® ... fingerprint readers have been deployed throughout First Bank ... , South Carolina and ... in Southern Pines, North Carolina ...
(Date:12/3/2014)... -- As part of our commitment to offering the ... announce the release of a new reader that will ... data that they need. The Atlas 2000 ... readers. Many such devices have serious shortcomings when it ... models force users to navigate numerous complicated steps in ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Inception Technologies to Release New Biometric Reader 2
... and sudden collapse of bee colonies across the country, but Penn ... triggers colony deaths which includes suppression of the bee immune system ... bee parasite that feeds much like a tick on the body ... pin head, dark brown in color and visible on close inspection. ...
... their genetic material from distantly related bacteria species, according ... Tucson. , The finding has important biomedical implications because ... many pathogenic bacteria pick up antibiotic resistance or become ... new antibiotics, it's important to monitor the rates and ...
... infected with HIV-1 engage a primitive defense mechanism ... invertebrates. The research also reveals exactly how HIV-1 ... vertebrate cells. However, elucidation of the mechanism HIV-1 ... into a potential vulnerability within the HIV-1 molecule. ...
Cached Biology News:Bee mites suppress bee immunity, open door for viruses and bacteria 2Bee mites suppress bee immunity, open door for viruses and bacteria 3Where bacteria get their genes 2Where bacteria get their genes 3Ancient immune defense mechanism is no match for HIV-1 2
(Date:12/24/2014)... 23, 2014 PharmaBoardroom,s new ... today and available for free download , digs deep ... and growth in the sector today. One area ... has been in developing a homegrown pharmaceutical manufacturing base, even ... still remains some way off. A cursory comparison with neighboring ...
(Date:12/24/2014)... 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... a Clinical Trial Application (CTA) with the ... (MHRA) seeking regulatory approval to initiate clinical trials for ... Contingent on the Company receiving CTA regulatory ... trial to assess the safety, tolerability and dose escalation ...
(Date:12/22/2014)... PA & Brussels (PRWEB) December 22, 2014 ... (CfPIE), the global leader of technical training across ... Society for Clinical Data Management (SCDM) to provide ... and certification programs —providing access to the more ... partnership extends SCDM members with 10% off when registering ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ - RepliCel Life ... regenerative medicine company focused on the development of autologous ... out of the University of Calgary in conjunction with ... Carolina, which further validates the company,s ongoing clinical research ... effects of pattern baldness. The paper entitled ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5
... BEIJING , Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the "Company") ... participate at the,following investor conferences in March 2010 : , , Investor Conference ... Location, Rodman & Renshaw Annual ... ...
... , Full enrollment occurs five months ahead of ... 8 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") ... Phase 2 clinical study of its lead drug RVX-208. "The ... full 5 months ahead of our original schedule, is a ...
... ... agency, announced today that it has been selected by Invida Group, the leading provider ... communications and public relations program. , ... Salem, MA (Vocus) February 8, 2010 -- LaVoie Group , ...
Cached Biology Technology:China Medical Technologies to Participate Investor Conferences in March 2010 2Resverlogix Completes Patient Recruitment for ASSERT Trial 2Resverlogix Completes Patient Recruitment for ASSERT Trial 3Resverlogix Completes Patient Recruitment for ASSERT Trial 4Invida Selects LaVoie Group as Public Relations Agency of Record 2Invida Selects LaVoie Group as Public Relations Agency of Record 3
Request Info...
The Synergy HT utilizes a unique dual-optics design combined with monochromator wavelength selection to provide uncompromised performance in absorbance, fluorescence and luminescence reading modes. ...
... Green I nucleic acid gel stain is ... has bright fluorescence when bound to dsDNA and ... detecting dsDNA in gels using laser scanners or ... stain has also found uses in capillary electrophoresis, ...
Synonym: modified Grace's Insect medium...
Biology Products: